Before Adam Sharples became a molecular physiologist studying muscle memory, he played professional rugby. Over his years as an athlete, he noticed that he and his teammates seemed to return to form ...
Pumping iron isn’t the only way to pump the brakes on age-related muscle loss. While weight training has long been lauded as the key to building and maintaining muscle mass, experts say there are ...
Specific key efficacy findings from cohort B (N=80) of the Phase 2/3 open-label, single-arm multi-center QUILT-3.032 study include: 1 The DFS rate at 12 months (primary endpoint) was 58.2% (95% CI ...
CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced treatment with ANKTIVA® (nogapendekin alfa inbakicept-pmln) plus Bacillus ...
ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced treatment with ANKTIVA® (nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) demonstrates efficacy ...
Papillary muscle scarring (papSCAR) is prevalent in one-third of DCM patients and predicts cardiac death independently. The FIDDLE technique significantly improves papSCAR detection sensitivity ...
We conducted an international, open-label, randomized, blinded-outcome-assessment trial involving 1284 patients who had undergone successful catheter ablation for atrial fibrillation at least 1 year ...
Background: Papillary Muscle (PM) related ventricular arrhythmia ablation is associated with lower acute success and suboptimal long-term outcomes due to complex anatomy, variable arrhythmogenic sites ...
Papillary muscle scarring in DCM patients is associated with higher risks of cardiac death, heart failure, and arrhythmia events. Microvascular dysfunction is a strong predictor of poor prognosis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results